These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11771755)

  • 1. Expression patterns of chaperone proteins in cerebral cortex of the fetus with Down syndrome: dysregulation of T-complex protein 1.
    Yoo BC; Fountoulakis M; Dierssen M; Lubec G
    J Neural Transm Suppl; 2001; (61):321-34. PubMed ID: 11771755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of molecular chaperones in brain of patients with Down syndrome.
    Yoo BC; Vlkolinsky R; Engidawork E; Cairns N; Fountoulakis M; Lubec G
    Electrophoresis; 2001 Apr; 22(6):1233-41. PubMed ID: 11358150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease.
    Yoo BC; Kim SH; Cairns N; Fountoulakis M; Lubec G
    Biochem Biophys Res Commun; 2001 Jan; 280(1):249-58. PubMed ID: 11162507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain t-complex polypeptide 1 (TCP- 1) related to its natural substrate beta1 tubulin is decreased in Alzheimer's disease.
    Schuller E; Gulesserian T; Seidl R; Cairns N; Lube G
    Life Sci; 2001 Jun; 69(3):263-70. PubMed ID: 11441917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of signaling-related proteins 14-3-3 gamma and RACK1 in fetal Down syndrome brain (trisomy 21).
    Peyrl A; Weitzdoerfer R; Gulesserian T; Fountoulakis M; Lubec G
    Electrophoresis; 2002 Jan; 23(1):152-7. PubMed ID: 11824616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of centractin and capping proteins, integral constituents of the dynactin complex, in fetal down syndrome brain.
    Gulesserian T; Kim SH; Fountoulakis M; Lubec G
    Biochem Biophys Res Commun; 2002 Feb; 291(1):62-7. PubMed ID: 11829462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unaltered expression of Fas (CD95/APO-1), caspase-3, Bcl-2 and annexins in brains of fetal Down syndrome: evidence against increased apoptosis.
    Engidawork E; Balic N; Juranville JF; Fountoulakis M; Dierssen M; Lubec G
    J Neural Transm Suppl; 2001; (61):149-62. PubMed ID: 11771740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased protein levels of complex I 30-kDa subunit in fetal Down syndrome brains.
    Kim SH; Fountoulakis M; Dierssen M; Lubec G
    J Neural Transm Suppl; 2001; (61):109-16. PubMed ID: 11771736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deranged hypothetical proteins Rik protein, Nit protein 2 and mitochondrial inner membrane protein, Mitofilin, in fetal Down syndrome brain.
    Myung J; Gulesserian T; Fountoulakis M; Lubec G
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):739-46. PubMed ID: 14528910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptosomal proteins, beta-soluble N-ethylmaleimide-sensitive factor attachment protein (beta-SNAP), gamma-SNAP and synaptotagmin I in brain of patients with Down syndrome and Alzheimer's disease.
    Yoo BC; Cairns N; Fountoulakis M; Lubec G
    Dement Geriatr Cogn Disord; 2001; 12(3):219-25. PubMed ID: 11244216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased protein levels of stathmin in adult brains with Down syndrome and Alzheimer's disease.
    Cheon MS; Fountoulakis M; Cairns NJ; Dierssen M; Herkner K; Lubec G
    J Neural Transm Suppl; 2001; (61):281-8. PubMed ID: 11771751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased brain levels of 2',3'-cyclic nucleotide-3'-phosphodiesterase in Down syndrome and Alzheimer's disease.
    Vlkolinský R; Cairns N; Fountoulakis M; Lubec G
    Neurobiol Aging; 2001; 22(4):547-53. PubMed ID: 11445254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective upregulation of the ubiquitin-proteasome proteolytic pathway proteins, proteasome zeta chain and isopeptidase T in fetal Down syndrome.
    Engidawork E; Juranville JF; Fountoulakis M; Dierssen M; Lubec G
    J Neural Transm Suppl; 2001; (61):117-30. PubMed ID: 11771738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derangement of hypothetical proteins in fetal Down's syndrome brain.
    Shin JH; Gulesserian T; Weitzdoerfer R; Fountoulakis M; Lubec G
    Neurochem Res; 2004 Jun; 29(6):1307-16. PubMed ID: 15176487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of dihydropyrimidinase related proteins-2,-3 and -4 in fetal Down syndrome brain.
    Weitzdoerfer R; Fountoulakis M; Lubec G
    J Neural Transm Suppl; 2001; (61):95-107. PubMed ID: 11771764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant protein expression in cerebral cortex of fetus with Down syndrome.
    Engidawork E; Gulesserian T; Fountoulakis M; Lubec G
    Neuroscience; 2003; 122(1):145-54. PubMed ID: 14596856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profiles of proteins in fetal brain with Down syndrome.
    Cheon MS; Fountoulakis M; Dierssen M; Ferreres JC; Lubec G
    J Neural Transm Suppl; 2001; (61):311-9. PubMed ID: 11771754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsp and chaperone distribution during endochondral bone development in mouse embryo.
    Loones MT; Morange M
    Cell Stress Chaperones; 1998 Dec; 3(4):237-44. PubMed ID: 9880236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons.
    Helguera P; Pelsman A; Pigino G; Wolvetang E; Head E; Busciglio J
    J Neurosci; 2005 Mar; 25(9):2295-303. PubMed ID: 15745955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A gel-based proteomic method reveals several protein pathway abnormalities in fetal Down syndrome brain.
    Sun Y; Dierssen M; Toran N; Pollak DD; Chen WQ; Lubec G
    J Proteomics; 2011 Apr; 74(4):547-57. PubMed ID: 21262400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.